Progesterone News and Research

RSS

"Baby brain" a real clinical entity finds study

Pregnant women are often forgetful and inattentive. This is called “baby brain” and has been recognized as a real entity by researchers now.

15 Jan 2018

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

12 Jan 2018

UC scientists identify protein that acts as mediator of HER2-driven breast cancer

Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential therapeutic target.

9 Jan 2018

Women who conceive while using IUD more likely to have adverse perinatal outcomes

Women who conceive while using an intrauterine contraceptive device have a greater risk of preterm delivery, low birth weight babies, bacterial infections, or losing a fetus, according to researchers at Ben-Gurion University of the Negev and the Soroka University Medical Center.

8 Jan 2018

UVA scientists working to find end-around method to stop triple-negative breast cancer

So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

20 Nov 2017

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Researchers at the Icahn School of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth of a common type of breast cancer known as "estrogen receptor positive" (ER+), including ER+ cancers that are resistant to standard treatments.

17 Nov 2017

New study further validates use of vaginal progesterone to decrease risk of preterm birth

A new study published today - World Prematurity Day - in the American Journal of Obstetrics & Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.

17 Nov 2017

Vaginal progesterone decreases the risk of premature birth in women with short cervix

A meta-analysis of placebo-controlled data published today indicates that vaginal progesterone reduces preterm birth and neonatal complications in women with a mid-trimester short cervix.

17 Nov 2017

Researchers find low levels of neuroactive steroid in both obese and anorexic women

Women at opposite extremes of the weight spectrum have low levels of the neuroactive steroid allopregnanolone, according to new research published in the journal Neuropsychopharmacology.

10 Nov 2017

Gene targets for triple negative breast cancers resistant to chemotherapy found

Researchers have finally found the genetic targets that could be used for treatment and development of new drugs in patients who are resistant to chemotherapy. These patients who are resistant to chemotherapy are most likely to have triple negative breast cancer which is the most aggressive form of breast cancer. The study appeared in the latest issue of the journal Cell Metabolism.

4 Oct 2017

Research uncovers potential targets for treatment of triple negative breast cancer

Research led by Dr. Carlos Arteaga, Director of the Harold C. Simmons Comprehensive Cancer Center, has identified potential targets for treatment of triple negative breast cancer, the most aggressive form of breast cancer.

3 Oct 2017

Pregnant women with endometriosis have greater risk for complications during pregnancy and delivery

A new meta-analysis shows that pregnant women with endometriosis are at greater risk for a host of complications during pregnancy and at delivery, including preterm birth and cesarean section. The study was published in the journal Fertility and Sterility.

13 Sep 2017

Researchers synthesizing new, first-in-class drug to stop growth of ER-positive breast cancer

Researchers at UT Health San Antonio and two partner institutions are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive (ER-positive) breast cancer in its tracks.

30 Aug 2017

Scientists discover novel lineage-restricted stem cell in the mammary gland

One of the key questions in stem cell and cancer biology is to understand the cellular hierarchy governing tissue development and maintenance and the cancer cell of origin.

16 Aug 2017

Freezing of IVF embryos more likely to increase pregnancy rates, study finds

A delay in transferring embryos to the mother improves the success of in vitro fertilization in certain cases, according to a study by scientists at the Stanford University School of Medicine, Celmatix Inc. and several other institutions.

1 Aug 2017

Study offers potential new strategy for use of retinoids against some breast cancers

Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment -- and breast cancers with higher CK5 expression have poorer prognosis.

26 Jul 2017

Male fish mutating into females - A toxicological fallout from remnants of human medicines in the ecosystems

According to lead researcher in the field of ecotoxicology, human medicines that end up in the ecosystem are causing mutations in the male fish that mutate them into females. Professor Charles Tyler, fish physiologist and eco-toxicologist from Exeter University, has warned that more and more scientists should work on the exact impact of these drugs and chemicals on nature and marine animals.

3 Jul 2017

Preserved placenta is associated with risk of infection

A recent case study published by Centers for Disease Control and Prevention highlighted that capsules of dehydrated placenta prepared for human consumption can be a source of infectious agents.

30 Jun 2017

Cryopreservation of Embryos to Improve Assisted Reproductive Technology

If we were to compare the progression of cryopreservation technology during recent years, we would find that from 2004 to 2013 over a timeframe of a decade, there has been around a 2.5 times increase in the rate of frozen-thawed embryo transfers (FETs) that were reported to the Society for Assisted Reproductive Technology (SART). While the rate of fresh embryo transfers (ET) that were completed was the same.

From Sofia Hospital of Obstetrics, Gynecology and Reproductive Medicine 19 Jun 2017

Penn State scientists win grant to develop novel approach to contraception

Two Penn State researchers have received a grant through the Grand Challenges Explorations program -- an initiative funded by the Bill & Melinda Gates Foundation -- to develop a novel approach to contraception.

15 Jun 2017

Progesterone News and Research

"Baby brain" a real clinical entity finds study

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

UC scientists identify protein that acts as mediator of HER2-driven breast cancer

Women who conceive while using IUD more likely to have adverse perinatal outcomes

UVA scientists working to find end-around method to stop triple-negative breast cancer

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

New study further validates use of vaginal progesterone to decrease risk of preterm birth

Vaginal progesterone decreases the risk of premature birth in women with short cervix

Researchers find low levels of neuroactive steroid in both obese and anorexic women

Gene targets for triple negative breast cancers resistant to chemotherapy found

Research uncovers potential targets for treatment of triple negative breast cancer

Pregnant women with endometriosis have greater risk for complications during pregnancy and delivery

Researchers synthesizing new, first-in-class drug to stop growth of ER-positive breast cancer

Scientists discover novel lineage-restricted stem cell in the mammary gland

Freezing of IVF embryos more likely to increase pregnancy rates, study finds

Study offers potential new strategy for use of retinoids against some breast cancers

Male fish mutating into females - A toxicological fallout from remnants of human medicines in the ecosystems

Preserved placenta is associated with risk of infection

Cryopreservation of Embryos to Improve Assisted Reproductive Technology

Penn State scientists win grant to develop novel approach to contraception

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News